TABLE 3.

Summary of treatment-emergent adverse events

System order class preferred term	No. (%) of patients
	Nonelderly		Elderly
	Male (n = 12)	Female (n = 12)	Male (n = 12)	Female (n = 12)
Overall	3 (25)	2 (16.7)	2 (16.7)	8 (66.7)
Abdominal pain	1 (8.3)	0	0	0
Constipation	0	0	0	1 (8.3)
Diarrhea	1 (8.3)	0	0	0
Hematochezia	0	0	0	1 (8.3)
Nausea	0	0	0	1 (8.3)
Dizziness	1 (8.3)	0	0	1 (8.3)
Headache	0	0	0	2 (16.7)
Presyncope	0	0	1 (8.3)	0
Influenza-like illness	1 (8.3)	0	0	0
Infusion site extravasation	0	0	1 (8.3)	0
Tenderness	0	0	0	1 (8.3)
Skin laceration	0	1 (8.3)	0	0
Thermal burn	0	0	0	1 (8.3)
Nasopharyngitis	0	1 (8.3)	0	0
Vulvovaginal infection	0	1 (8.3)	0	0
Hepatic enzyme increase	0	0	0	1 (8.3)
Back pain	0	0	0	1 (8.3)